GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Zentek Ltd.
Zentek is a technology company developing nanomaterials, including for medical applications. Its stock price represents a venture capital bet on the commercialization of its research, which carries high risks and uncertainty.
Share prices of companies in the market segment - Medical instruments
Zentek develops and commercializes nanotechnology solutions for healthcare, including antiviral coatings and pathogen detection systems. We classify it as part of the Medical Instruments sector. The chart below illustrates the dynamics of this innovative segment.
Broad Market Index - GURU.Markets
Zentek is a Canadian company that develops and manufactures graphene-based nanomaterials for medical and industrial applications. As an innovator, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Zentek's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
ZTEK - Daily change in the company's share price Zentek Ltd.
The daily price change of Zentek Ltd., a developer of innovative materials, including for medical applications, reflects the volatility of R&D companies. This indicator demonstrates sensitivity to patent news and technology commercialization, making it an important element of analysis.
Daily change in the price of a set of shares in a market segment - Medical instruments
Zentek Ltd. is a company developing innovative materials. This chart highlights the high volatility of the tech sector. A comparison with ZTEK's performance, with its focus on graphene, helps to assess it as a high-risk tech stock.
Daily change in the price of a broad market stock, index - GURU.Markets
Zentek develops and commercializes nanotechnology, including for use in medical masks. This innovative company's shares reflect advances in materials science and its ability to bring products to market, adding unique volatility to the overall picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Zentek Ltd.
For Zentek Ltd., year-over-year performance is a story about the commercialization of its graphene-based technologies. Its 12-month market cap depends on the success of its ZenGUARDโข antimicrobial coating in personal protective equipment and air filtration systems, as well as the development of other areas, such as fuel additives.
Annual dynamics of market capitalization of the market segment - Medical instruments
Zentek Ltd. is a technology company developing graphene-based materials for a variety of applications, from medicine to industry. Its stock price is extremely volatile, reflecting investor confidence in its breakthrough potential and ability to commercialize its unique technology.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zentek, developing graphene-based technologies, is a speculative bet on the future of materials. Its stock price is not tied to the economy, but rather driven by its technological breakthroughs and partnerships. The chart tells the story of investors' faith in its innovation's widespread application in industry and medicine.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Zentek Ltd.
Zentek develops and commercializes nanotechnology, including for medical masks. Its monthly performance depends on the success of its product launches. News about regulatory approvals, supply contracts, and new applications for its technology are the main drivers.
Monthly dynamics of market capitalization of the market segment - Medical instruments
Zentek develops and commercializes graphene-based nanotechnology, including for use in antiviral-coated medical masks and other industrial applications. The chart below shows the dynamics of the advanced materials sector, where nanotechnology promises to revolutionize.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Zentek develops graphene-based nanotechnology for various industries, including medicine. It's a venture-backed company whose value is based on the potential of its developments. Its shares are driven by patent and commercialization news, completely ignoring overall market trends.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Zentek Ltd.
Zentek, a company developing nanotechnology solutions, including antimicrobial coatings, exhibits high volatility. Weekly stock performance is driven by news about the commercialization of its technologies, partnerships, and regulatory approvals, reflecting expectations for innovative materials.
Weekly dynamics of market capitalization of the market segment - Medical instruments
Zentek develops nanotechnology for medical and other applications. For an innovative company, it's important to understand how the market perceives its potential. The chart will show whether Zentek stands out in its sector, which could signal breakthrough technologies, or whether its performance is simply following general trends.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Zentek develops nanotechnology for a variety of applications. As a company at the cutting edge of science, its shares can be highly volatile. The chart will show whether they are prone to amplify market movements, reflecting investors' appetite for risky technology plays, or whether they are simply settling into their own territory.
Market capitalization of the company, segment and market as a whole
ZTEK - Market capitalization of the company Zentek Ltd.
Zentek's market capitalization is a financial bet on innovative materials. The company's stock price, which develops graphene-based products for medical and industrial applications, reflects investors' faith in the technology's potential. Its volatility reflects the hopes and risks associated with the commercialization of cutting-edge scientific research.
ZTEK - Share of the company's market capitalization Zentek Ltd. within the market segment - Medical instruments
Zentek's market share in the medical materials sector reflects its status as an innovator in nanotechnology. Its market share is determined not by production volumes, but by its intellectual property and the breakthrough potential of its developments, which could change standards in the fields of defense and medicine.
Market capitalization of the market segment - Medical instruments
Zentek develops innovative graphene-based materials for various applications, including medical ones. The chart below shows the overall market capitalization of the entire medical equipment sector. Its dynamics reflect the ongoing search for new materials and technologies to improve diagnostics and treatment.
Market capitalization of all companies included in a broad market index - GURU.Markets
Zentek develops and commercializes nanotechnology, specifically antimicrobial coatings for medical masks and other applications. Its market capitalization is a bet on the future of nanomaterials. The chart below shows the economic impact of innovation in this field.
Book value capitalization of the company, segment and market as a whole
ZTEK - Book value capitalization of the company Zentek Ltd.
Zentek's book value is derived from its capital and R&D equipment for developing innovative materials such as graphene. The chart below shows the material and financial basis for scientific breakthroughs. Its growth reflects investments in technologies with potential applications ranging from medicine to aerospace.
ZTEK - Share of the company's book capitalization Zentek Ltd. within the market segment - Medical instruments
Zentek develops innovative graphene-based materials for various applications, including medical ones. Its strength lies in its laboratories and pilot production facilities. The share price chart shows how the company is building its physical foundation for the commercialization of future technologies.
Market segment balance sheet capitalization - Medical instruments
Zentek develops nanomaterials, but its business model is "light." Its core value lies in patents and technology, not giant factories. Is this focus on intelligence, rather than concrete, the norm for this segment? The chart below reveals the true "weight" of the entire advanced materials industry.
Book value of all companies included in the broad market index - GURU.Markets
Zentek's balance sheet is not based on production lines, but rather on patents for unique graphene-based nanomaterials and capital for their commercialization in medicine and industry. The book value chart shows the amount of resources invested in this breakthrough technology with broad application potential.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Zentek Ltd.
Zentek develops nanomaterials, including those with antimicrobial properties, for medical masks. The company has virtually no tangible assets. Its entire market capitalization is based on the commercial success of its patented technology. The chart shows how the market values โโthe company's intellectual property in advanced materials.
Market to book capitalization ratio in a market segment - Medical instruments
Zentek develops nanotechnology for medical and other applications, such as protective coatings. The company's value is based almost entirely on its patents and scientific potential. The chart demonstrates how much investor expectations for future commercial products exceed the value of its current tangible assets.
Market to book capitalization ratio for the market as a whole
Zentek develops and commercializes nanotechnology, particularly graphene-based nanotechnology, for applications in various industries, including healthcare. This chart shows how the market perceives the potential of this breakthrough material. The company's market capitalization, reflecting its bet on the broad commercial application of its developments, is many times greater than its current assets.
Debts of the company, segment and market as a whole
ZTEK - Company debts Zentek Ltd.
Zentek develops and commercializes nanotechnology solutions for various industries, including medicine. For the company, debt instruments can be a way to finance production scaling and entry into new markets during the commercialization stage. This chart shows how Zentek raises capital to transform science into product.
Market segment debts - Medical instruments
Zentek develops and commercializes nanotechnology for use in various fields, including medical devices such as antimicrobial masks. This business requires significant investment in research and development. The chart shows the financial requirements for the advanced materials sector, where raising capital is key to turning laboratory discoveries into products.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Zentek Ltd.
Zentek develops and commercializes nanomaterials, including for medical applications. Developing such technologies requires lengthy and expensive research. This chart shows the company's reliance on debt to finance R&D. It reflects both the lenders' faith in the technology and the financial risks involved before achieving profitability.
Market segment debt to market segment book capitalization - Medical instruments
Developing innovative materials like graphene for medical and industrial applications, as Zentek does, requires significant research investment. This chart shows the debt burden in the high-tech sector. It allows one to assess how a company finances its R&D activities compared to established manufacturers.
Debt to book value of all companies in the market
Zentek develops innovative graphene-based materials for various industries. Science-intensive companies often raise debt during the R&D phase to finance breakthrough technologies. The chart provides context, allowing one to evaluate their debt strategy against the overall level of market leverage.
P/E of the company, segment and market as a whole
P/E - Zentek Ltd.
This chart shows the valuation of Zentek Ltd., a company developing nanotechnology, including for medical applications. For a company whose value is based on innovation and intellectual property, this metric reflects not so much current profits as investors' faith in the future commercial potential of its developments.
P/E of the market segment - Medical instruments
This chart shows the average valuation for the advanced materials sector, which includes Zentek. In this innovative industry, the average valuation reflects the overall level of investor confidence in the commercialization of new technologies. It provides context for understanding how the market views the potential of Zentek's nanotechnology.
P/E of the market as a whole
Zentek develops and commercializes nanotechnology, including for use in medical masks and other products. The company's valuation is a bet on the widespread use of its innovative materials. This chart shows the overall market interest in new technologies. It helps us understand whether Zentek's valuation is part of the general hype surrounding nanotechnology or is backed by actual contracts.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Zentek Ltd.
Zentek develops and commercializes nanotechnology, particularly graphene-based nanotechnology, for applications in various fields, including medical devices and corrosion protection. The company's future depends on the successful implementation of its technologies. This graph reflects speculative market expectations regarding the commercial potential of its developments and their potential for widespread application.
Future (projected) P/E of the market segment - Medical instruments
Zentek develops and commercializes nanotechnology, particularly graphene-based nanotechnology, for applications in various fields, including medicine (coatings for PPE) and industry. It is a business at the cutting edge of materials science. The chart shows sector expectations, helping to assess the market's confidence in the commercial potential of Zentek's breakthrough technologies.
Future (projected) P/E of the market as a whole
Zentek develops and commercializes nanotechnology, specifically materials with antimicrobial properties for use in medical masks and filtration systems. This chart of overall expectations reflects investor sentiment toward innovation. Market optimism and increased attention to healthcare make it easier for companies like Zentek to raise capital to bring their cutting-edge developments to market.
Profit of the company, segment and market as a whole
Company profit Zentek Ltd.
Zentek develops and commercializes nanotechnology for applications in healthcare and other industries, such as antimicrobial coatings. This graph illustrates the company's journey from research to market. Revenue will depend on successful technology licensing and supply contracts for materials using its innovations.
Profit of companies in the market segment - Medical instruments
Investcorp Credit Management (ICMB) is a business development company (BDC) that provides loans to mid-market companies. Its profitability depends on the quality of its loan portfolio and interest rates. This chart shows how the financial health of American mid-market businesses directly impacts the profitability of these investment companies, making them a barometer of the real sector.
Overall market profit
Zentek is a Canadian technology company developing nanomaterials, including those with antimicrobial properties, for use in medical masks and filtration systems. The company's success depends on the commercialization of its innovative developments. Zentek's growth demonstrates how new materials can find application in a wide range of industries, from healthcare to manufacturing.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Zentek Ltd.
Zentek develops and commercializes nanotechnology, particularly graphene-based nanotechnology, for healthcare applications, such as in personal protective equipment with antiviral coatings. The profit forecast for such an innovative company depends on the successful commercialization of its developments. This chart shows analysts' speculative expectations for the future of the nanomaterials market.
Future (predicted) profit of companies in the market segment - Medical instruments
Zentek develops and commercializes graphene-based nanotechnology for use in a wide range of applications, from medical masks to corrosion-resistant coatings. It is a science-intensive company with broad potential. This chart shows profitability forecasts for the advanced materials sector, reflecting the market's confidence in the rapid commercialization of such breakthrough technologies.
Future (predicted) profit of the market as a whole
Zentek develops and commercializes nanotechnology, including for medical instruments and coatings. While demand for innovative medical products is often inelastic, the overall investment climate is critical for R&D funding. This market return forecast chart helps assess how likely investors are to invest in cutting-edge technologies.
P/S of the company, segment and market as a whole
P/S - Zentek Ltd.
Zentek develops and commercializes nanotechnology, specifically graphene-based coatings with antimicrobial properties for use in medical devices such as masks. Its revenue is in the early stages. The chart reflects investor expectations regarding the commercial potential of its innovative materials and their applications in healthcare and other industries.
P/S market segment - Medical instruments
Zentek Ltd. is a company developing and commercializing intellectual property based on graphene and other nanomaterials for healthcare and industrial applications. Revenue is at an early stage. This chart reflects the average valuation in the sector, allowing one to assess the market's perception of the future revenue potential of Zentek's technologies.
P/S of the market as a whole
Zentek develops nanomaterials, particularly graphene-based ones, for medical and industrial applications, such as antimicrobial coatings. The company operates at the intersection of science and commerce. This chart, showing average valuations, helps understand how expectations for breakthrough materials influence the company's valuation compared to traditional businesses.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Zentek Ltd.
Zentek develops and commercializes nanotechnology solutions for various applications, including healthcare and the environment. This chart reflects investor expectations for future revenue from licensing and sales of its products. The valuation is based on confidence in the commercial potential of its innovative materials, such as those with antimicrobial properties.
Future (projected) P/S of the market segment - Medical instruments
Zentek Ltd. develops and commercializes nanotechnology, including graphene coatings with antimicrobial properties for medical devices and air filtration systems. This chart shows how the market values โโZentek's future revenue, reflecting investor confidence in the commercial potential of its innovative materials and technologies in healthcare.
Future (projected) P/S of the market as a whole
Market optimism about future revenues hinges on innovative materials. Zentek is developing graphene-based materials for a variety of applications, including medical masks with antiviral coatings. Their ability to find commercial applications for cutting-edge scientific research demonstrates how new technologies can create markets and drive overall economic growth.
Sales of the company, segment and market as a whole
Company sales Zentek Ltd.
Zentek develops and commercializes nanotechnology, particularly graphene, for applications in various fields, including healthcare. The company's revenue currently comes from sales of products such as protective masks with antimicrobial coatings. This chart shows the company's initial steps toward monetizing its cutting-edge research.
Sales of companies in the market segment - Medical instruments
Zentek Ltd. develops and commercializes nanotechnology solutions for healthcare and other industries, including antimicrobial coatings for medical masks. This chart shows total revenue in the medical instruments sector. It illustrates the market need for innovative materials to improve safety, a niche Zentek is pursuing.
Overall market sales
Zentek develops and commercializes nanotechnology, particularly graphene-based nanotechnology, for healthcare applications, such as the production of personal protective equipment with antimicrobial properties. The company's success depends on the implementation of innovative materials. This graph of overall economic activity reflects the industry's willingness to invest in new, more advanced technologies.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Zentek Ltd.
Zentek develops and commercializes graphene-based nanotechnology for various applications, including medical masks with antiviral coatings and fuel additives. The company's future depends on the commercialization of its developments. The chart reflects speculative analyst forecasts, which are betting on the widespread adoption of graphene technologies.
Future (projected) sales of companies in the market segment - Medical instruments
Zentek develops and commercializes nanotechnology, including antimicrobial coatings for medical devices. The company's success depends on the implementation of its innovative materials. This chart shows projected sales for the entire medical instrument sector, reflecting overall expectations for demand for new technologies in healthcare.
Future (projected) sales of the market as a whole
Zentek develops nanomaterials for use in various fields, including medical PPE and fuel cells. Commercialization of its technologies depends on the adoption of innovations in industry. This overall business activity chart reflects manufacturers' willingness to invest in new materials to improve their products, which creates a market for Zentek.
Marginality of the company, segment and market as a whole
Company marginality Zentek Ltd.
Zentek develops and commercializes nanotechnology, including medical applications. This metric reflects its journey from the lab to the marketplace. It demonstrates how successfully the company is converting licensing and sales revenue into net profit, covering ongoing research and development costs.
Market segment marginality - Medical instruments
Zentek Ltd. develops nanotechnology solutions for medical and other applications, such as enhancing the effectiveness of personal protective equipment. Profitability depends on the commercialization of these innovations. This metric reflects the company's operational structure at the market launch stage, compared to other companies in the advanced materials sector.
Market marginality as a whole
Zentek develops and commercializes nanotechnology for use in a variety of fields, including medical instruments and protective coatings. Their success depends on innovation. This gross margin chart demonstrates the industry's willingness to invest in new materials and technologies. Increased profitability among potential clients accelerates collaboration decisions.
Employees in the company, segment and market as a whole
Number of employees in the company Zentek Ltd.
Zentek develops nanomaterials for a variety of applications, including medicine and the environment. As an R&D-focused company, its core scientific team forms the core. This graph shows the dynamics of the team of scientists and engineers working on the commercialization of cutting-edge technologies, such as antiviral coatings and fuel cleaning systems.
Share of the company's employees Zentek Ltd. within the market segment - Medical instruments
Zentek develops nanomaterials for use in healthcare and other industries. This chart shows the concentration of unique materials scientists. The proportion of such specialists within the company reflects its innovative focus on creating cutting-edge technologies, from antimicrobial coatings to fuel cells.
Number of employees in the market segment - Medical instruments
Zentek Ltd. develops and commercializes intellectual property based on graphene and other nanomaterials for various applications, including medicine. This chart shows overall employment in the medical instrument sector. It illustrates how the advanced materials developed by Zentek can be used to create the next generation of medical devices.
Number of employees in the market as a whole
Zentek Ltd. develops advanced nanomaterials, including for medical applications, such as enhancing the effectiveness of masks. It's a knowledge-intensive business, where every employee is a highly skilled specialist. This employment chart also reflects the contribution of these innovative companies, which, although small in size, create technologies that impact entire industries and safety.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Zentek Ltd. (ZTEK)
Zentek Ltd. develops innovative graphene-based materials for medical and industrial applications. This chart demonstrates the company's high intellectual capital valuation. The market sees enormous potential in this technology, which is why the company's market capitalization per employee is so high. The company's value lies in its patents and research and development, not its production capacity.
Market capitalization per employee (in thousands of dollars) in the market segment - Medical instruments
Zentek Ltd. develops and commercializes graphene-based intellectual property for various applications, including medicine. It's a knowledge-intensive business where a small team of researchers can create enormous value. This chart shows how the market values โโthe potential of their technology per employee, betting on future breakthroughs.
Market capitalization per employee (in thousands of dollars) for the overall market
Zentek Ltd. develops nanomaterials, particularly for use in medical devices and aerospace. It is a knowledge-intensive, early-stage business. The high valuation per employee reflects the investors' belief in the potential of this patented technology, which allows a small team of scientists to create a material with unique and sought-after properties.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Zentek Ltd. (ZTEK)
Zentek develops and commercializes intellectual property, primarily based on graphene, such as their antimicrobial coating "Zenguard." It's an R&D business focused on materials science. This chart shows how much the company spends (loss) per scientist and engineer in its efforts to bring this technology to the mass market.
Profit per employee (in thousands of dollars) in the market segment - Medical instruments
Zentek is working at the forefront of materials science, commercializing graphene-based technologies. At the current, primarily R&D stage, this metric isn't key. The graph sets the bar for mature companies. Zentek's goal is to prove the uniqueness of its materials so that their future application in medicine or industry will generate extremely high returns per employee.
Profit per employee (in thousands of dollars) for the market as a whole
Zentek (ZTEK) develops and commercializes graphene-based technological solutions, particularly for medical applications (e.g., coated masks). This chart shows the effectiveness of their R&D and commercialization teams. While the company is focused on growth rather than maturity, its return per employee may be low or negative due to its investment in research.
Sales to employees of the company, segment and market as a whole
Sales per company employee Zentek Ltd. (ZTEK)
For Zentek, a company developing nanomaterials for medical and industrial applications, this graph reflects the commercialization stage of its technologies. Increased revenue per employee will indicate the successful implementation of its innovative coatings and filters into real products.
Sales per employee in the market segment - Medical instruments
Zentek is a nanotechnology company, specifically graphene, with medical applications (e.g., antiviral coatings). It has deep R&D capabilities. This metric reflects the average revenue per employee in the segment. It helps assess how productive Zentek's research team is in commercializing its developments compared to other companies in the advanced materials sector.
Sales per employee for the market as a whole
Zentek (ZTEK) is a company developing and commercializing graphene-based technologies, including for medical PPE (e.g., masks). This metric tracks their transition from R&D to actual production. Increasing revenue per employee (primarily scientists) will signal that their innovative materials are finding applications and are starting to generate revenue.
Short shares by company, segment and market as a whole
Shares shorted by company Zentek Ltd. (ZTEK)
Zentek Ltd. is a company attempting to commercialize graphene technology for various applications, including medical masks and coatings. It is a speculative venture, dependent on successful R&D. This chart reflects investor bets that its technology will not find widespread commercial application or will be too expensive to manufacture, despite its stated potential.
Shares shorted by market segment - Medical instruments
Zentek (ZTEK) is a company developing and commercializing nanomaterials, including for use in medical devices such as antiviral-coated PPE. This indicator represents a general short position in the advanced materials sector, reflecting the collective skepticism of investors regarding the timeline for the actual commercialization and scalability of such innovations.
Shares shorted by the overall market
Zentek (ZTEK) is an R&D company working with graphene. It's a speculative bet on the "material of the future." When this market fear indicator rises, investors are unwilling to fund "science." They're selling off "concept stocks" en masse without profit, fearing ZTEK will run out of cash.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Zentek Ltd. (ZTEK)
Zentek is an R&D company betting on the "miracle material" graphene. They're trying to apply it to everything from medicine to batteries. It's pure speculation on the technology. This chart measures the level of hype. It shows when the euphoria from announcements (overbought) or the despondency from delays (oversold) reach extremes.
RSI 14 Market Segment - Medical instruments
Zentek (ZTEK) is "graphene" 2.0. It's a materials science company that uses graphene to create advanced products (like ZenGUARD mask filters). The medical instruments sector thrives on R&D. RSI_14_Seg shows whether the entire sector is overbought. This helps differentiate: is ZTEK's growth a niche or a general hype?
RSI 14 for the overall market
Zentek (ZTEK) is pure hype. This chart demonstrates the appetite for speculation. During periods of euphoria, investors are willing to "buy the dream" and invest in "green" R&D projects. In moments of panic, investors flee unprofitable "concepts," and these stocks are the first to be sold off.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ZTEK (Zentek Ltd.)
Zentek develops and commercializes nanotechnology, including graphene, for use in medical masks (ZenGUARD coating), HVAC filters, and other applications. This chart shows the average analyst forecast. Their targets are based on the successful commercialization of ZenGUARD and the development of new graphene-based products.
The difference between the consensus estimate and the actual stock price ZTEK (Zentek Ltd.)
Zentek is a Canadian technology company developing nanomaterials, specifically their flagship product, the "ZenGUARD" coating, which has antiviral properties. This chart shows how the current share price differs from the "fair" value predicted by analysts. It reflects their belief in the commercialization of this nanotechnology.
Analyst consensus forecast for stock prices by market segment - Medical instruments
Zentek is a Canadian technology company developing nanomaterials (graphene) for use in medical masks (antimicrobial) and industrial applications. This chart reflects general expectations for the medical instrument sector. It shows whether experts believe the "miracle material" graphene will be commercially successful.
Analysts' consensus forecast for the overall market share price
Zentek (ZTEK) is a Canadian R&D company working with the "miracle material" graphene. Their flagship product is an antiviral coating (ZenGUARD) for medical masks and filters. This chart shows the overall risk appetite. It reflects the market's willingness to invest in speculative "science" companies dependent on a single product.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Zentek Ltd.
Zentek is a 21st-century wonder material. They're an R&D company focused on graphene, a nanomaterial they're trying to integrate into everything from HVAC filters (to kill COVID) to ice coatings for airplanes. This graph is pure hype and R&D. It reflects their (very slow) path to commercialization and the market's faith in their magical material.
AKIMA Market Segment Index - Medical instruments
Zentek is a Canadian technology company developing graphene-based materials, specifically the ZenGUARD coating, which has antiviral properties for PPE. This chart shows the average index for the medical instrument sector. It allows investors to assess the potential of Zentek's innovative material.
The AKIM Index for the overall market
Zentek is a technology company specializing in nanomaterials (graphene) for healthcare (masks, filters) and HVAC. This chart, which reflects the market average, is just a backdrop. It helps us assess how this history of materials patent commercialization compares to overall macroeconomic trends.